Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Tobramycin Inhalant Product
DRUG
2 trials
Sponsors
Guangzhou Institute of Respiratory Disease
, Shanghai Pulmonary Hospital, Shanghai, China
Conditions
Bronchiectasis Adult
Pseudomonas Aeruginosa Infection
Pseudomonas Infections
Phase 3
Tobramycin in Bronchiectasis Colonized With Pseudmonas Aeruginosa
NCT03715322
Guangzhou Institute of Respiratory Disease
Bronchiectasis Adult, Pseudomonas Infections
Start: 2018-10-26
End: 2021-06-30
Target: 350
Updated: 2019-08-02
Phase 4
Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis
Recruiting
NCT06093191
Shanghai Pulmonary Hospital, Shanghai, China
Bronchiectasis Adult, Pseudomonas Aeruginosa Infection
Start: 2023-09-25
End: 2025-12-30
Target: 364
Updated: 2024-12-18
Related Papers
A phase 4 multicentre, 2×2 factorial randomised, double-blind, placebo-controlled trial to investigate the efficacy and safety of tobramycin inhalation solution for<i>Pseudomonas aeruginosa</i>eradication in bronchiectasis: ERASE
ERJ Open Research
2024-01-01
5 citations
A Double-Blind Randomized Placebo-Controlled Phase 3 Trial of Tobramycin Inhalation Solution in Adults With Bronchiectasis With Pseudomonas aeruginosa Infection.
2022-07-19
37 citations